相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Systematic Nomenclature for the Redox States of High Mobility Group Box (HMGB) Proteins
Daniel J. Antoine et al.
MOLECULAR MEDICINE (2014)
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Tobias Bald et al.
NATURE (2014)
Serum HMGB1 as a Diagnostic Marker for Malignant Peritoneal Mesothelioma
Chiharu Tabata et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Cyclooxygenase-2 Deficiency in Macrophages Leads to Defective p110γ PI3K Signaling and Impairs Cell Adhesion and Migration
Manuel D. Diaz-Munoz et al.
JOURNAL OF IMMUNOLOGY (2013)
COX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugs
Evrim Gurpinar et al.
FRONTIERS IN ONCOLOGY (2013)
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Sandro Jube et al.
CANCER RESEARCH (2012)
Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
Hye Won Chung et al.
CANCER SCIENCE (2012)
Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma
Michele Carbone et al.
CLINICAL CANCER RESEARCH (2012)
Malignant Mesothelioma: Facts, Myths, and Hypotheses
Michele Carbone et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
被撤回的出版物: Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference (Retracted article. See vol. 230, pg. 2579, 2015)
Jie Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Michele Carbone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
Hanna Lee et al.
PLOS ONE (2012)
Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation
Haining Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Masquerader: High mobility group box-1 and cancer
Jessica E. Ellerman et al.
CLINICAL CANCER RESEARCH (2007)
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
CM Ulrich et al.
NATURE REVIEWS CANCER (2006)
COX-2: A molecular target for colorectal cancer prevention
JR Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
H Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway
S Gardella et al.
EMBO REPORTS (2002)
Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis -: art. no. 19
BK Reuter et al.
BMC CANCER (2002)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
分享论文
